Tirzepatide Weight Loss for MRD+ Early Breast Cancer

Clinical trial NCT06517212 · RECRUITING

Trial details

NCT number: NCT06517212
Sponsor: Baylor Research Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Breast Neoplasms Breast Cancers

Start date: 2024-11-26
Primary completion: 2029-08-31
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.